Bray, R. A., Gebel, H. M., Townsend, R., Roberts, M. E., Polinsky, M., Yang, L., . . . Larsen, C. P. (2018). Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT. Am J Transplant.
Citação norma ChicagoBray, R. A., H. M. Gebel, R. Townsend, M. E. Roberts, M. Polinsky, L. Yang, H.‐U Meier‐Kriesche, and C. P. Larsen. "Posttransplant Reduction in Preexisting Donor‐specific Antibody Levels After Belatacept‐ Versus Cyclosporine‐based Immunosuppression: Post Hoc Analyses of BENEFIT and BENEFIT‐EXT." Am J Transplant 2018.
Citação norma MLABray, R. A., et al. "Posttransplant Reduction in Preexisting Donor‐specific Antibody Levels After Belatacept‐ Versus Cyclosporine‐based Immunosuppression: Post Hoc Analyses of BENEFIT and BENEFIT‐EXT." Am J Transplant 2018.